Document:

EX-10.13

 Exhibit 10.13 

AMENDED AND RESTATED EMPLOYMENT AGREEMENT 

This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”), dated May 25, 2016, is by and among Fulgent
Therapeutics LLC, a California limited liability company (the “Company”), Fulgent Diagnostics, Inc., a Delaware corporation (“HoldCo”) and Hanlin Gao (“Executive”). 

WHEREAS, the Company and Executive previously entered into that certain Employment Agreement, dated as of March 31, 2013
(“Original Agreement”); and 
 WHEREAS, the Company, HoldCo and Executive desire to amend and restate the Original Agreement
as further set forth herein. 
 1. POSITION AND RESPONSIBILITIES 

(a) Position. Executive is employed by the Company to render services to the Company in the position of Chief Scientific Officer and
Lab Director. Executive shall perform such duties and responsibilities as are normally related to such positions in accordance with the standards of the industry and any additional duties now or hereafter assigned to Executive by the Company.
Executive shall abide by the rules, regulations, policies, procedures and practices as adopted or modified from time to time in the Company’s sole discretion. 

(b) Other Activities. Except upon the prior written consent of the Company, Executive will not, during the term of this Agreement,
(i) accept any other employment, or (ii) engage, directly or indirectly, in any other business activity (whether or not pursued for pecuniary advantage) that might interfere with Executive’s duties and responsibilities hereunder or
create a conflict of interest with the Company. Notwithstanding the foregoing, Executive may continue to serve as a lab inspector for the College of American Pathologists, provided that Executive’s scope of duties in such capacity does not
increase beyond Executive’s scope of duties in such capacity as of the date hereof. 
 (c) No Conflict. Executive represents and
warrants that Executive’s execution of this Agreement, Executive’s employment with the Company, and the performance of Executive’s proposed duties under this Agreement shall not violate any obligations Executive may have to any other
employer, person or entity, including any obligations with respect to proprietary or confidential information of any other person or entity. 

2. COMPENSATION AND BENEFITS 

(a) Base Salary. In consideration of the services to be rendered under this Agreement, the Company shall pay Executive a salary at the
rate of One Hundred Eighty Thousand Dollars ($180,000) per year (“Base Salary”). Upon completion of an initial public offering of HoldCo’s shares under an effective registration statement filed under the Securities Act of 1933,
as amended, Executive’s Base Salary shall be Two Hundred Ten Thousand Dollars ($210,000) per year. The Base Salary shall be paid in accordance with the Company’s regularly established payroll practice. Executive’s Base Salary will be
reviewed from time to time in accordance with the established procedures of the Company for adjusting salaries for similarly-situated employees and may be adjusted in the sole discretion of the Company. 

  
 1 

 (b) Benefits. Executive shall be eligible to participate in the benefits made generally
available by the Company to similarly-situated employees, in accordance with the benefit plans established by the Company, and as may be amended from time to time in the Company’s sole discretion. 

(c) Bonus and Equity Compensation. Executive may be eligible for an annual cash bonus or equity compensation. Any such bonus or equity
compensation, including applicable terms and conditions, shall be determined by the Manager of the Company in its sole discretion. Executive must remain employed by the Company for the full fiscal year in order to be eligible for a bonus for that
fiscal year. 
 (d) Expenses. The Company shall reimburse Executive for reasonable business expenses incurred in the performance of
Executive’s duties hereunder in accordance with the Company’s expense reimbursement guidelines. 
 3. AT-WILL
EMPLOYMENT 
 (a) At-Will Termination by Company. Executive’s employment with the Company shall be
“at-will” at all times. The Company may terminate Executive’s employment with the Company at any time, without any advance notice, for any reason or no reason at all, notwithstanding anything to the contrary contained in or arising
from any statements, policies, procedures or practices of the Company relating to the employment, discipline or termination of its employees. Upon and after such termination, all obligations of the Company under this Agreement shall cease, except as
otherwise provided herein. 
 (b) At-Will Termination by Executive. Executive may terminate employment with the Company at any time
for any reason or no reason at all, upon written notice. Thereafter all obligations of the Company shall cease. 
 (c) Payment. Upon
termination of Executive’s employment, the Company shall pay to Executive all compensation to which Executive is entitled up through the date of termination, subject to any other rights or remedies of the Company under law; and thereafter all
of the obligations of the Company under this Agreement shall cease. 
 4. TERMINATION OBLIGATIONS 

(a) Return of Property. Executive agrees that all property (including without limitation all equipment, tangible proprietary
information, documents, records, notes, contracts and computer-generated materials) furnished to or created or prepared by Executive incident to Executive’s employment belongs to the Company and shall be promptly returned to the Company upon
termination of Executive’s employment. 
 (b) Resignation and Cooperation. Unless otherwise agreed in writing, upon termination
of Executive’s employment, Executive shall be deemed to have resigned from all offices and directorships then held with the Company. Following any termination of employment, Executive shall cooperate with the Company in the winding up of
pending work on behalf of the Company and the orderly transfer of work to other employees. Executive shall also cooperate with the Company in the defense of any action brought by any third party against the Company that relates to Executive’s
employment by the Company. 
 (c) Continuing Obligations. Executive understands and agrees that Executive’s obligations under
Sections 4 and 5 (including the Proprietary Information Agreement (as defined below)) shall survive the termination of Executive’s employment for any reason and the termination of this Agreement. 

  
 2 

 5. INVENTIONS AND PROPRIETARY INFORMATION; PROHIBITION ON THIRD PARTY
INFORMATION 
 (a) Proprietary Information Agreement. Prior to the date hereof, Executive has signed the Company’s
Proprietary Information and Invention Assignment Agreement (“Proprietary Information Agreement”) and delivered such signed Proprietary Information Agreement to the Company. 

(b) Non-Disclosure of Third Party Information. Executive represents and warrants and covenants that Executive shall not disclose to the
Company, or use, or induce the Company to use, any proprietary information or trade secrets of others at any time, including but not limited to any proprietary information or trade secrets of any former employer, if any; and Executive acknowledges
and agrees that any violation of this provision shall be grounds for Executive’s immediate termination and could subject Executive to substantial civil liabilities and criminal penalties. Executive further specifically and expressly
acknowledges that no officer or other employee or representative of the Company has requested or instructed Executive to disclose or use any such third party proprietary information or trade secrets. 

6. AMENDMENTS; WAIVERS; REMEDIES 

This Agreement may not be amended or waived except by a writing signed by Executive and by a duly authorized representative of the Company other than
Executive. Failure to exercise any right under this Agreement shall not constitute a waiver of such right. Any waiver of any breach of this Agreement shall not operate as a waiver of any subsequent breaches. All rights or remedies specified for a
party herein shall be cumulative and in addition to all other rights and remedies of the party hereunder or under applicable law. 
 7.
ASSIGNMENT; BINDING EFFECT 
 (a) Assignment. The performance of Executive is personal hereunder, and Executive
agrees that Executive shall have no right to assign and shall not assign or purport to assign any rights or obligations under this Agreement. This Agreement may be assigned or transferred by the Company; and nothing in this Agreement shall prevent
the consolidation, merger or sale of the Company or a sale of any or all or substantially all of its assets. 
 (b) Binding Effect.
Subject to the foregoing restriction on assignment by Executive, this Agreement shall inure to the benefit of and be binding upon each of the parties; the affiliates, officers, directors, agents, successors and assigns of the Company; and the heirs,
devisees, spouses, legal representatives and successors of Executive. 

  
 3 

 8. SEVERABILITY 

If any provision of this Agreement shall be held by a court or arbitrator to be invalid, unenforceable, or void, such provision shall be enforced to the
fullest extent permitted by law, and the remainder of this Agreement shall remain in full force and effect. 
 9. TAXES

 All amounts paid under this Agreement (including, without limitation, Base Salary) shall be paid less all applicable state and federal tax
withholdings and any other withholdings required by any applicable jurisdiction or authorized by Executive. Notwithstanding any other provision of this Agreement whatsoever, the Company, in its sole discretion, shall have the right to provide for
the application and effects of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) (relating to deferred compensation arrangements), and any related administrative guidance issued by the Internal Revenue
Service. The Company shall have the authority to delay the payment of any amounts under this Agreement to the extent it deems necessary or appropriate to comply with Section 409A(a)(2)(B)(i) of the Code (relating to payments made to certain
“key employees” of publicly-traded companies); in such event, the payment(s) at issue may not be made before the date which is six (6) months after the date of Executive’s separation from service, or, if earlier, the date of
death. 
 10. GOVERNING LAW 

This Agreement shall be governed by and construed in accordance with the laws of the State of California. 

11. INTERPRETATION 
 This
Agreement shall be construed as a whole, according to its fair meaning, and not in favor of or against any party. Sections and section headings contained in this Agreement are for reference purposes only, and shall not affect in any manner the
meaning or interpretation of this Agreement. Whenever the context requires, references to the singular shall include the plural and the plural the singular. 

12. COUNTERPARTS 
 This
Agreement may be executed in any number of counterparts, each of which shall be deemed an original of this Agreement, but all of which together shall constitute one and the same instrument. 

13. AUTHORITY 
 Each party
represents and warrants that such party has the right, power and authority to enter into and execute this Agreement and to perform and discharge all of the obligations hereunder; and that this Agreement constitutes the valid and legally binding
agreement and obligation of such party and is enforceable in accordance with its terms. 

  
 4 

 14. ENTIRE AGREEMENT 

This Agreement amends and restates the Original Agreement in its entirety. This Agreement is intended to be the final, complete, and exclusive statement of
the terms of Executive’s employment by the Company and may not be contradicted by evidence of any prior or contemporaneous statements or agreements, except for agreements specifically referenced herein (including the Proprietary Information
Agreement). To the extent that the practices, policies or procedures of the Company, now or in the future, apply to Executive and are inconsistent with the terms of this Agreement, the provisions of this Agreement shall control. Any subsequent
change in Executive’s duties, position, or compensation will not affect the validity or scope of this Agreement. 
 15.
EXECUTIVE ACKNOWLEDGEMENT 
 EXECUTIVE ACKNOWLEDGES EXECUTIVE HAS HAD THE OPPORTUNITY TO CONSULT LEGAL COUNSEL CONCERNING THIS
AGREEMENT, THAT EXECUTIVE HAS READ AND UNDERSTANDS THE AGREEMENT, THAT EXECUTIVE IS FULLY AWARE OF ITS LEGAL EFFECT, AND THAT EXECUTIVE HAS ENTERED INTO IT FREELY BASED ON EXECUTIVE’S OWN JUDGMENT AND NOT ON ANY REPRESENTATIONS OR PROMISES
OTHER THAN THOSE CONTAINED IN THIS AGREEMENT. 
 (Signature Page Follows) 

  
 5 

 IN WITNESS WHEREOF, the parties have duly
executed this Agreement as of the date first written above. 
  

							
	FULGENT THERAPEUTICS LLC:	 		 	HANLIN GAO:
				
	By:	 	 /s/ Ming Hsieh
	 		 	 /s/ Hanlin Gao

				
	Name:	 	Ming Hsieh	 		 	
				
	Title:	 	Manager	 		 	
			
	FULGENT DIAGNOSTICS, INC.:	 		 	
				
	By:	 	 /s/ Ming Hsieh
	 		 	
				
	Name:	 	Ming Hsieh	 		 	
				
	Title:	 	President	 		 	

 SIGNATURE PAGE TO AMENDED AND
RESTATED EMPLOYMENT AGREEMENTEX-10.14

 Exhibit 10.14 

SEVERANCE AGREEMENT 
 This
SEVERANCE AGREEMENT (the “Agreement”), dated July 7, 2016, is by and among Fulgent Therapeutics LLC, a California limited liability company (the “Company”), Fulgent Diagnostics, Inc., a Delaware
corporation (“HoldCo”) and Ming Hsieh (“Executive”). 
 WHEREAS, Executive is employed by the Company to
render services to the Company in the position of President and Chief Executive Officer and HoldCo in the position of President and Chief Executive Officer; and 

WHEREAS, the Company, HoldCo and Executive desire to provide for certain rights of Executive with respect to severance payments due to
Executive in the event of a termination of employment following a Change in Control (as defined below). 
 NOW, THEREFORE, in consideration
of the mutual promises, covenants and agreements set forth in this Agreement, the sufficiency of which the parties acknowledge, it is agreed as follows: 
  

	 	1.	DEFINED TERMS 

 Defined terms, when used in this Agreement, shall have the meaning ascribed thereto in
this Section 1 or elsewhere in this Agreement. 
 (a) “Base Salary” means Executive’s annualized base salary,
determined based on the rate of pay in effect during the last regularly scheduled payroll period immediately preceding the Change in Control. Base Salary does not include any bonuses, commissions, fringe benefits, overtime, car allowances, other
irregular payments or any other compensation except base salary. 
 (b) “Board” means the Board of Directors of HoldCo.

 (c) “Change in Control” means (i) any Person (other than the Company or HoldCo, any trustee or other fiduciary
holding securities under any employee benefit plan of the Company or HoldCo, or any company owned, directly or indirectly, by the beneficial owners of voting securities the Company or HoldCo in substantially the same proportions as their ownership
of voting securities of the Company or HoldCo), becoming the beneficial owner (as defined in Rule 13d 3 under the Exchange Act), directly or indirectly, of securities of the Company or Holdco representing more than fifty percent (50%) of the
combined voting power of the Company’s or Holdco’s then outstanding securities, (ii) during any twelve (12) month period, individuals who, as of the effective date of HoldCo’s initial public offering pursuant to a
registration statement under the Securities Act, constitute the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a
director subsequent to such initial public offering whose election, or nomination for election by HoldCo’s shareholders, was approved by a vote of at least two-thirds of the directors then comprising the Incumbent Board shall be considered as
though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or
removal of directors or other actual or threatened 

  
 1 

 
solicitation of proxies or consents by or on behalf of a Person other than the Board, (iii) a merger or consolidation of the Company or HoldCo with any other entity, other than a merger or
consolidation which would result in the voting securities of such entity outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than
50% of the combined voting power of the voting securities of the Company or HoldCo (as applicable) or such surviving entity outstanding immediately after such merger or consolidation; provided, however, that a merger or consolidation
effected to implement a recapitalization of the Company or HoldCo (or similar transaction) in which no Person (other than those covered by the exceptions in subsection (i) above) acquires more than fifty percent (50%) of the combined
voting power of the Company’s or HoldCo’s (as applicable) then outstanding securities shall not constitute a Change in Control for purposes of this Agreement, or (iv) a complete liquidation or dissolution of the Company or HoldCo or
the consummation of a sale or disposition by the Company or HoldCo of all or substantially all of its assets, other than the sale or disposition of all or substantially all of such assets to a Person or Persons who beneficially own, directly or
indirectly, 50% or more of the combined voting power of the outstanding voting securities of the Company or HoldCo at the time of the sale; provided, further, that notwithstanding the foregoing, to the extent required to avoid payments
under this Agreement being subject to any accelerated or additional tax under Section 409A of the Code, a Change in Control shall not be deemed to have occurred under this Agreement unless the transaction or event constituting would also
constitute a “change in control event” (as defined in Treasury Regulation §1.409A-3(i)(5)). 
 (d) “Code”
means the Internal Revenue Code of 1986, as amended. 
 (e) “Exchange Act” means the Securities Exchange Act of 1934, as
amended. 
 (f) “Person” means an individual, entity group or group (within the meaning of Sections 13(d)(3) or 14(d)(2) of
the Exchange Act). 
 (g) “Securities Act” means the Securities Act of 1933, as amended. 

 

	 	2.	SEVERANCE 

 (a) If Executive’s employment is terminated by the Company, HoldCo or
Executive for any reason at any time during the period commencing on the date of the Change in Control and ending on the one (1)-year anniversary thereof, Executive shall be entitled to receive an amount equal to one (1) year of
Executive’s Base Salary, payable in accordance with the Company’s regular payroll practices (collectively, the “Severance”); provided, however, that Executive’s right to receive the Severance shall be subject
to (i) execution and delivery by Executive of a release agreement in substantially the form attached as Exhibit A, and (ii) such release agreement becoming irrevocable not later than sixty (60) days after Executive’s
employment terminates. If the foregoing conditions are satisfied, the Severance payments will commence (subject to any required delay pursuant to Section 6), within ninety (90) days following the termination date, on the first payroll date
following the date the release agreement becomes irrevocable (with the first payment including any installments that otherwise would have been paid between the date of termination and the date of such first installment); provided, however,
that if the ninety (90) day period described above spans calendar years, the Severance will commence in the second calendar year. 

  
 2 

	 	3.	AMENDMENTS; WAIVERS; REMEDIES 

 This Agreement may not be amended or waived except by a writing signed by
Executive and a duly authorized representative of each of the Company and HoldCo other than Executive. Failure to exercise any right under this Agreement shall not constitute a waiver of such right. Any waiver of any breach of this Agreement shall
not operate as a waiver of any subsequent breaches. All rights or remedies specified for a party herein shall be cumulative and in addition to all other rights and remedies of the party hereunder or under applicable law. 

 

	 	4.	ASSIGNMENT; BINDING EFFECT 

 (a) Assignment. This Agreement may not be assigned or
transferred, except with the prior written consent of each of the parties hereto. 
 (b) Binding Effect. Subject to the foregoing
restriction on assignment, this Agreement shall inure to the benefit of and be binding upon each of the parties, the affiliates, officers, directors, agents, successors and assigns of the Company and HoldCo, and the heirs, devisees, spouses, legal
representatives and successors of Executive. 
  

	 	5.	SEVERABILITY 

 If any provision of this Agreement shall be held by a court or arbitrator to be invalid,
unenforceable, or void, such provision shall be enforced to the fullest extent permitted by law, and the remainder of this Agreement shall remain in full force and effect. 
  

	 	6.	TAXES 

 All amounts paid under this Agreement shall be paid less all applicable state and federal tax
withholdings and any other withholdings required by any applicable jurisdiction or authorized by Executive. To the extent applicable, it is intended that this Agreement and any payment made hereunder will comply with the requirements of (or an
exemption or exclusion from) Section 409A of the Code, and any related regulations or other guidance promulgated with respect to such section by the U.S. Department of the Treasury or the Internal Revenue Service (“Section 409A”), and
any ambiguities in this Agreement will be interpreted accordingly. Any provision of this Agreement that would cause this Agreement to fail to satisfy Section 409A will have no force and effect until amended to comply therewith (which amendment
may be retroactive to the extent permitted by Section 409A). Notwithstanding anything contained herein to the contrary, to the extent required in order to avoid accelerated taxation and/or tax penalties under Section 409A, Executive will
not be considered to have terminated employment with the Company for purposes of this Agreement and no payments will be due to Executive under this Agreement which are payable upon Executive’s termination of employment until Executive would be
considered to have incurred a “separation from service” from the Company within the meaning of Section 409A. To the extent required in order to avoid accelerated taxation and/or tax penalties under Section 409A (as determined by
the Company and Executive), amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to this 

  
 3 

 
Agreement during the six (6)-month period immediately following Executive’s termination of employment shall instead be paid on the first business day after the date that is six
(6) months following Executive’s termination of employment (or upon Executive’s death, if earlier). Payments of Severance pursuant to this Agreement are intended to constitute a series of separate payments for purposes of Treasury
Regulation §1.409A-2(b)(2)(iii). The Company and HoldCo shall consult with Executive in good faith regarding the implementation of the provisions of this Section 6. Notwithstanding anything herein to the contrary, none of the Company,
HoldCo their respective affiliates, or their respective employees, members, managers, agents or representatives shall have any liability to Executive with respect to any taxes, penalties, interest or other costs or expenses Executive or any related
party may incur under Code Section 409A or for damages for failing to comply with Code Section 409A. 
  

	 	7.	GOVERNING LAW 

 This Agreement shall be governed by and construed in accordance with the laws of the
State of California. 
  

	 	8.	INTERPRETATION 

 This Agreement shall be construed as a whole, according to its fair meaning, and not in
favor of or against any party. Sections and section headings contained in this Agreement are for reference purposes only, and shall not affect in any manner the meaning or interpretation of this Agreement. Whenever the context requires, references
to the singular shall include the plural and the plural the singular. 
  

	 	9.	COUNTERPARTS 

 This Agreement may be executed in any number of counterparts, each of which shall be
deemed an original of this Agreement, but all of which together shall constitute one and the same instrument. 
  

	 	10.	AUTHORITY 

 Each party represents and warrants that such party has the right, power and authority to
enter into and execute this Agreement and to perform and discharge all of the obligations hereunder; and that this Agreement constitutes the valid and legally binding agreement and obligation of such party and is enforceable in accordance with its
terms. 
  

	 	11.	ENTIRE AGREEMENT 

 This Agreement is intended to be the final, complete, and exclusive statement of the
terms of Executive’s severance rights from the Company and HoldCo and may not be contradicted by evidence of any prior or contemporaneous statements or agreements, except for agreements specifically referenced herein. Any Severance paid or
payable under this Agreement shall be in lieu of (and not in addition to) any other severance to which Executive may otherwise be entitled. To the extent that any plans, practices, policies, agreements or arrangements of the Company, HoldCo or their
respective affiliates, as applicable, now or in the future, apply to Executive and are inconsistent with the terms of this Agreement, the provisions of this Agreement shall control. Any subsequent change in Executive’s duties, position, or
compensation will not affect the validity or scope of this Agreement. 

  
 4 

	 	12.	EXECUTIVE ACKNOWLEDGEMENT 

 EXECUTIVE ACKNOWLEDGES EXECUTIVE HAS HAD THE OPPORTUNITY TO CONSULT LEGAL
COUNSEL CONCERNING THIS AGREEMENT, THAT EXECUTIVE HAS READ AND UNDERSTANDS THE AGREEMENT, THAT EXECUTIVE IS FULLY AWARE OF ITS LEGAL EFFECT, AND THAT EXECUTIVE HAS ENTERED INTO IT FREELY BASED ON EXECUTIVE’S OWN JUDGMENT AND NOT ON ANY
REPRESENTATIONS OR PROMISES OTHER THAN THOSE CONTAINED IN THIS AGREEMENT. 
 (Signature Page Follows) 

  
 5 

 IN WITNESS WHEREOF, the parties have duly
executed this Agreement as of the date first written above. 
  

									
	FULGENT THERAPEUTICS LLC:	 		 	MING HSIEH:
				
	By:	 	 /s/ Paul Kim
	 		 	 /s/ Ming Hsieh

	Name:	 	Paul Kim	 		 		 	
	Title:	 	Chief Financial Officer	 		 		 	
				
	FULGENT DIAGNOSTICS, INC.:	 		 		 	
					
	By:	 	 /s/ Paul Kim
	 		 		 	
	Name:	 	Paul Kim	 		 		 	
	Title:	 	Chief Financial Officer	 		 		 	

  
 SIGNATURE
PAGE TO SEVERANCE AGREEMENT 

 EXHIBIT A 

FORM OF RELEASE AGREEMENT 
 This
RELEASE AGREEMENT (the “Release Agreement”), dated [●], 20[●], by and among Fulgent Therapeutics LLC, a California limited liability company (the “Company”), Fulgent Diagnostics, Inc., a Delaware
corporation (“HoldCo”) and Ming Hsieh (“Executive”). 
 WHEREAS, the Company, HoldCo and
Executive are parties to that certain Severance Agreement, dated [●], 2016 (the “Severance Agreement”), pursuant to which Executive is eligible to receive severance benefits, contingent upon certain conditions set forth in the
Severance Agreement. All capitalized terms used but not otherwise defined herein shall have the meaning ascribed to them in the Severance Agreement; 

WHEREAS, the Company, HoldCo and Executive are parties to that certain Employment Agreement, dated May 25, 2016
(“Employment Agreement”); and 
 WHEREAS, one such condition set forth in the Severance Agreement to
receiving the severance benefits is Executive’s execution, delivery and non-revocation of this Release Agreement. 
 NOW, THEREFORE, in
consideration of the mutual promises, covenants and agreements set forth in this Release Agreement, the sufficiency of which the parties acknowledge, it is agreed as follows: 

1. In exchange for the general release of claims and other agreements contained in this Release Agreement, Executive will receive the
Severance as set forth in the Severance Agreement following Executive’s execution and subsequent non-revocation of this Release Agreement during any applicable statutory revocation period. 

2. Executive agrees not to disparage the Company or HoldCo, and its and their officers, directors, employees, shareholders, members and
agents, in any manner likely to be harmful to them or their business, business reputation, or personal reputation. 
 3. In exchange for the
separation benefits described above, Executive completely releases the Company and HoldCo, and each of its and their affiliated, related, parent or subsidiary entities, and each of its and their present and former officers, directors, employees,
shareholders, members and agents (the “Released Parties”) from any and all claims of any kind, known and unknown, which Executive may now have or have ever had against any of them. This release includes all claims arising from
Executive’s employment with the Company and/or HoldCo and its and their termination, including claims under the California Fair Employment and Housing Act, Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act, as
amended, or any other claims for violation of any federal, state, or municipal statutes, any and all claims in contract or tort or premised on any other legal theory and any and all claims for attorneys’ fees and costs; provided,
however, that nothing in this Release Agreement shall (a) waive any rights or claims of Executive that arise after this Release Agreement becomes effective, (b) impair or preclude Executive’s right to take action to enforce

 
the terms of this Release Agreement, (c) impair Executive’s vested rights under any tax-qualified retirement plan maintained by the Company, HoldCo and its and their affiliates, or
(d) impair Executive’s rights to indemnification under any indemnification agreement(s) between Executive and the Company or HoldCo, as applicable, any rights to and claims for indemnification or as an insured under any directors and
officers liability insurance policy in connection with Executive’s service as an officer, employee or agent of the Company or HoldCo, as applicable, or any of its and their subsidiaries and affiliates, under their respective certificates of
incorporation, by-laws or operating agreements, or otherwise as provided by law. Executive agrees not to file, cause to be filed, or otherwise pursue any claims released by this paragraph. Notwithstanding the foregoing, Executive acknowledges and
understands that Executive is not waiving and is not being required to waive any right that cannot be waived by law, including the right to file a charge or participate in an administrative investigation or proceeding; provided,
however, that Executive hereby disclaims and waives any right to share or participate in any monetary award resulting from the prosecution of such charge or investigation. 

4. It is the Company’s and Executive’s intention that the foregoing release shall be construed in the broadest sense possible, and
shall be effective as a prohibition to all claims, charges, actions, suits, demands, obligations, damages, injuries, liabilities, losses, and causes of action of every character, nature, kind or description, known or unknown, and suspected or
unsuspected that Executive may have against the Released Parties. 
 Executive expressly acknowledges that he is aware of the existence of
California Civil Code § 1542 and its meaning and effect. Executive expressly acknowledges that he has read and understands the following provision of that section, which provides: 

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF
EXECUTING THE RELEASE, WHICH IF KNOWN BY HER OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR. 
 Executive
expressly waives and releases any right to benefits he may have under California Civil Code § 1542 to the fullest extent he may do so lawfully. Executive further acknowledges that he may later discover facts different from, or in addition
to, those facts now known to him or believed by him to be true with respect to any or all of the matters covered by this Release Agreement, and he agrees this Release Agreement nevertheless shall remain in full and complete force and effect. 

5. Executive acknowledges that the Severance as set forth in the Severance Agreement exceeds the amount to which Executive otherwise is
entitled should Executive not execute, deliver and not revoke this Release Agreement, each within the applicable periods set forth in this Release Agreement. Executive understands and agrees that this Release Agreement shall be maintained in strict
confidence, and that Executive shall not disclose any of its terms to another person, except legal counsel, unless required by law. [Executive further acknowledges that Executive has received the Disclosure under Title 29 U.S. Code
Section 626(f)(1)(H) which is attached hereto as Exhibit 1.] 

 6. Executive agrees to return all Company and HoldCo materials in Executive’s possession.
Executive shall comply with Executive’s continuing obligations under the Proprietary Information and Invention Assignment Agreement (the “Proprietary Information Agreement”). 

7. Executive acknowledges that Executive has [twenty-one (21)][forty-five (45)] days to consider this Release Agreement (but may sign it at
any time beforehand if Executive so desires), and that Executive is advised to consult an attorney in doing so. Executive hereby acknowledges that Executive understands the significance of this Release Agreement, and represents that the terms of
this Release Agreement are fully understood and voluntarily accepted by Executive. Executive also acknowledges that Executive can revoke this Release Agreement within seven (7) days of signing it by sending a letter to that effect at the
following address: 
 Fulgent Diagnostics, Inc. 

Board of Directors 
 4978 Santa
Anita Ave. 
 Temple City, California 91780 

Executive understands and agree that this Release Agreement shall not become effective nor enforceable until the seven (7) day revocation period has
expired. 
 8. This Release Agreement and the Severance Agreement contain all of the parties’ agreements and understandings with
respect to the matters herein and fully supersede any prior agreements or understandings that the parties may have had regarding such matters, except for the Proprietary Information Agreement and the Employment Agreement. This Release Agreement
shall be governed by California law and may be amended only in a written document signed by Executive and duly authorized representative of each of the Company and HoldCo, other than Executive. If any term in this Release Agreement is unenforceable,
the remainder of the Release Agreement will remain enforceable. 
 9. If Executive wishes to accept the terms of this Release Agreement,
please sign below and return a copy of this Release Agreement to the Company between the last day of employment and [●], 20[●]. 

(Signature Page Follows) 

 IN WITNESS WHEREOF, the parties have duly
executed this Release Agreement as of the last date written below. 
  

									
	FULGENT THERAPEUTICS LLC:	 		 	MING HSIEH:
				
	By:	 	  
	 		 	  

	Name:	 	  
	 		 	  
 Date:
	 	  
  

	Title:	 	  
	 		 	 
	  
 Date:
	 	  
  
	 		 	 
				
	FULGENT DIAGNOSTICS, INC.:	 		 		 	
					
	By:	 	  
	 		 		 	
	Name:	 	  
	 		 		 	
	Title:	 	  
	 		 		 	
					
	Date:	 	  
	 		 		 	

  
 SIGNATURE
PAGE TO RELEASE AGREEMENT 

 EXHIBIT 1 

JOB TITLES AND AGES OF EMPLOYEES WHO WERE AND WERE NOT SELECTED FOR RIF: 
  

							
	 Selected for RIF
	 	 Eligible but not selected for RIF

	 Job Title
	 	 Age
	 	 Job Title
	 	 Age

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00262-of-00352.parquet"}]]